740 related articles for article (PubMed ID: 4454041)
1. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting.
Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR
Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo functions of thrombin-treated platelets.
Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
[TBL] [Abstract][Full Text] [Related]
3. Plasmin inhibition of thrombin-induced platelet aggregation.
Miller JL; Katz AJ; Feinstein MB
Thromb Diath Haemorrh; 1975 Apr; 33(2):286-309. PubMed ID: 124475
[TBL] [Abstract][Full Text] [Related]
4. Platelet interaction with polymerizing fibrin.
Niewiarowski S; Regoeczi E; Stewart GJ; Senyl AF; Mustard JF
J Clin Invest; 1972 Mar; 51(3):685-99. PubMed ID: 4622107
[TBL] [Abstract][Full Text] [Related]
5. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin.
Phillips DR
Thromb Diath Haemorrh; 1974 Sep; 32(1):207-15. PubMed ID: 4454040
[TBL] [Abstract][Full Text] [Related]
6. Impact of fibrinogen concentration in severely ill patients on mechanical properties of whole blood clots.
Dempfle CE; Kälsch T; Elmas E; Suvajac N; Lücke T; Münch E; Borggrefe M
Blood Coagul Fibrinolysis; 2008 Dec; 19(8):765-70. PubMed ID: 19002042
[TBL] [Abstract][Full Text] [Related]
7. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
8. Platelet microtubules in clot structure formation and contractile force generation: investigation of a controversy.
Jen CJ; McIntire LV
Thromb Haemost; 1986 Aug; 56(1):23-7. PubMed ID: 2877507
[TBL] [Abstract][Full Text] [Related]
9. Antithrombin activity of intact human platelets.
Watanabe K; Chao FC; Tullis JL
Thromb Diath Haemorrh; 1975 Sep; 34(1):115-26. PubMed ID: 52897
[TBL] [Abstract][Full Text] [Related]
10. Aggregation of platelets and inert particles induced by thrombin.
Chao FC; Tullis JL; Conneely GS; Lawler JW
Thromb Haemost; 1976 Jun; 35(3):717-36. PubMed ID: 10638
[TBL] [Abstract][Full Text] [Related]
11. Development of platelet contractile force as a research and clinical measure of platelet function.
Carr ME
Cell Biochem Biophys; 2003; 38(1):55-78. PubMed ID: 12663942
[TBL] [Abstract][Full Text] [Related]
12. Effect of amino sugars on platelet aggregation and on fibrinogen binding.
Kinlough-Rathbone RL; Packham MA; Mustard JF
Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
14. Effects of alpha-tocopherol on platelets and the coagulation system.
Bakaltcheva I; Gyimah D; Reid T
Platelets; 2001 Nov; 12(7):389-94. PubMed ID: 11674855
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
[TBL] [Abstract][Full Text] [Related]
16. Functional involvement of thrombospondin in platelet aggregation induced by low versus high concentrations of thrombin.
Kao KJ; Shaut DM; Klein PA
Thromb Haemost; 1986 Feb; 55(1):136-42. PubMed ID: 3705001
[TBL] [Abstract][Full Text] [Related]
17. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of bencyclan on coagulation, fibrinolysis and platelet function.
Ponari O; Civardi E; Dettori G; Magha A; Potì R; Bulletti G
Arzneimittelforschung; 1976; 26(8):1532-8. PubMed ID: 12770
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN.
Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653
[TBL] [Abstract][Full Text] [Related]
20. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
